Verseau Therapeutics Announces FDA Clearance of IND Application for VTX-0811
04 Jan 2022 //
BUSINESSWIRE
Verseau Therapeutics Appoints Karen Tubridy as Chief Development Officer
07 Sep 2021 //
BUSINESSWIRE
Applied BioMath Announces Collaboration with Verseau for System Pharmacology
03 Aug 2020 //
PRNEWSWIRE
3SBio Selects Verseau`s PSGL-1-targeted Antibody VTX-0811
18 Nov 2019 //
BIOSPACE
PSGL-1 immunotherapy to activate a anti-tumor inflammatory response
18 Nov 2019 //
BIOSPECTRUM ASIA